Cargando…
Psychopharmacology Today: Where are We and Where Do We Go From Here?
Since the 1950s we have had the same three neurotransmitters to work with to treat depression, one transmitter for psychoses, three for anxiety. We have developed newer drugs that are more tolerable, but we have not developed drugs that are better in efficacy. The last 50-60 years should be consider...
| Autor principal: | |
|---|---|
| Formato: | Texto |
| Lenguaje: | English |
| Publicado: |
Medknow Publications
2010
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3031936/ https://www.ncbi.nlm.nih.gov/pubmed/21327167 http://dx.doi.org/10.4103/0973-1229.58816 |